Pfizer and BioNTech’s Vaccine Could Be Available in Europe By The End Of The Year
Pfizer and BioNTech’s Vaccine Could Be Available in Europe By The End Of The Year- In a joint statement released by Pfizer and BioNTech, the adoption of a recommendation by European regulators in the form of conditional emergency implementation will accelerate the start of the use of the vaccine in Europe. Along with this development, the vaccine developed by Pfizer and Biontexch can start being administered in Europe by the end of the year.
Pfizer and its partner BioNTech have asked regulators in Europe for permission for the vaccine, which they have completed to work on.
The official application was made the previous day, while the vaccine audit, which began on October 6th in Europe, is expected to accelerate the approval process and the Covid-19 vaccine will receive approval by the end of the year.
In trials in November, it prevented 95% of symptomatic Covid-19 cases from reaching 44 thousand people and did not lead to a critical health safety problem.
